Company News »

Company Profile for Simulations Plus, Inc.

Business Wire
Share on StockTwits
Published on

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide. Our recently announced acquisition of Cognigen, Inc. of Buffalo, NY, which closed on September 2, 2014, will add top-quality clinical trial data analysis to our offerings, and will more than double our staff from 30 to 65, add nearly 50% to revenues, and add to earnings in the coming fiscal year that begins September 1.

Company:

Simulations Plus, Inc.

Headquarters Address:

42505 10th Street West
Lancaster, CA 93534

Main Telephone:

(661) 723-7723

Website:

www.simulations-plus.com

Ticker/ISIN:

SLP(NASDAQ)/US8292141053

Type of Organization:

Public
IR

Industry:

Pharmaceutical

Key Executives:

Chairman: Walter Woltosz

President: Thaddeus (“Ted”) Grasela

CFO: John Kneisel

Investor Relations

Contact:

Renee Bouche

Phone:

661-723-7723

Email:

renee@simulations-plus.com

Investor Relations

Contact:

Cameron Donahue

Phone:

651-653-1854

Email:

cameron@haydenir.com

Customer Service

Contact:

John DiBella

Phone:

661-723-7723

Email:

john.dibella@simulations-plus.com

Share on StockTwits